: A cancer treatment developer priced at $5.85 with projected EPS growth of over 70%.
: A software memory company whose stock price rose 78% to $3.30 in early January 2017. stocks under 10 dollars to buy 2017
: Noted as a market leader with strong free cash flow, trading under $10 and attracting attention from Berkshire Hathaway. Highly Volatile "Penny Stocks" of 2017 : A cancer treatment developer priced at $5
: An e-commerce service provider priced at $7.91 with a projected EPS growth of over 263% for the fiscal year. stocks under 10 dollars to buy 2017
: One of the best performers of 2017, climbing from $1.01 to over $5.25 following successful clinical trials. Investment Perspective for 2017
According to Zacks Investment Research and other analysts in 2017, the following stocks were noted for their performance potential: